Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces.

J Dabard1, C Bridonneau, C Phillipe

  • 1Unité d'Ecologie et de Physiologie du Système Digestif, Institut National de la Recherche Agronomique, 78352 Jouy-en-Josas Cedex, France.

Applied and Environmental Microbiology
|August 30, 2001
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2016
Same author

Long-term drug survival of biological agents in patients with rheumatoid arthritis in clinical practice.

Scandinavian journal of rheumatology·2016
Same author

A novel methodology for personalized simulations of ventricular hemodynamics from noninvasive imaging data.

Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society·2016
Same author

Strong inflammatory response and Th1-polarization profile in children with acute lymphoblastic leukemia without apparent infection.

Oncology reports·2016
Same author

Evaluation of GenoFlow DR-MTB Array Test for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis.

Journal of clinical microbiology·2016
Same author

Evolution of regional oxygen saturation in the peri-operative of thoracic surgery and its relationship with central venous saturation.

Revista espanola de anestesiologia y reanimacion·2015

Researchers discovered ruminococcin A, a novel bacteriocin produced by the anaerobic bacterium Ruminococcus gnavus. This lantibiotic shows activity against pathogenic clostridia and related bacteria.

Area of Science:

  • Microbiology
  • Biochemistry
  • Molecular Biology

Background:

  • The human gut microbiota harbors diverse anaerobic bacteria.
  • Antibacterial compounds produced by gut bacteria can influence host health.
  • Ruminococcus gnavus is a common inhabitant of the human fecal microbiota.

Purpose of the Study:

  • To characterize a novel antibacterial substance produced by Ruminococcus gnavus E1.
  • To determine the structure and properties of this bacteriocin.
  • To assess its activity against pathogenic bacteria.

Main Methods:

  • Bacterial cultivation and supernatant collection.
  • Purification using reverse-phase chromatography.
  • Structural analysis via Edman degradation, tandem mass spectrometry, and DNA sequencing.

Related Experiment Videos

  • Activity assays against target bacteria.

    • Main Results:

    • Isolation and purification of ruminococcin A, a 2,675-Da bacteriocin.
    • Identification of a lanthionine structure and 21 amino acid residues.
    • Classification of ruminococcin A as a class IIA lantibiotic.
    • Demonstrated activity against pathogenic clostridia and related bacteria.

    Conclusions:

    • Ruminococcin A is the first characterized bacteriocin from a strictly anaerobic bacterium in human fecal microbiota.
    • This finding expands the known repertoire of bacteriocins.
    • Ruminococcin A has potential as a therapeutic agent against specific bacterial pathogens.